Urinary Incontinence: Clinical Trials

107 trials for Urinary Incontinence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

71 completed, 14 unknown, 7 withdrawn, 5 active not recruiting. 107 Phase 2, 22 Phase 1, 18 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2107Completed 71, Unknown 14, Withdrawn 7, Active not recruiting 5, Terminated 5, Recruiting 4, Not yet recruiting 1
Phase 122Completed 11, Unknown 8, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 318Completed 11, Unknown 3, Withdrawn 2, Active not recruiting 1, Terminated 1

Follow Urinary Incontinence: new trials by email Literature Review of Urinary Incontinence trials Research Report on Urinary Incontinence

Trials (filtered) newest first · largest first

All 107 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy
Tadalafil 5 mg, Pelvic Floor Muscle Training (PFMT), Aerobic Exercise Program - Erectile Dysfunction Following Radical Prostatectomy, Prostate Cancer
Phase 2RecruitingSurgical Outcomes Research Centre (SOuRCe)642026-08-312026-10-23
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
CBD - Supra-sacral Spinal Cord Injury, Spinal Cord Injury
Phase 2RecruitingUniversity of Wisconsin, Madison202026-02-132026-09-16
COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis
Diaper with a copper-based product + usual care, Barrier product with common diaper - Incontinence-associated Dermatitis
Phase 2 / Phase 3WithdrawnHospital Israelita Albert Einstein2025-09-012026-01-12
A Phase 2a Study To Evaluate VMB-100 In Females With Stress Urinary Incontinence
VMB-100 - Stress Urinary Incontinence
Phase 2WithdrawnVersameb AG2025-09-012025-12-05
The Anabolic Effect of Testosterone on Pelvic Floor Muscles
Testosterone cypionate, Placebo - Stress Urinary Incontinence, Menopause
Phase 2Active not recruitingBrigham and Women's Hospital302025-02-152026-06-26
Cross-linked Hyaluronic Acid/dextranomer for the Treatment of Stress Urinary Incontinence
Intraurethral injection, Mid-urethral sling - Urinary Stress Incontinence (SI)
Phase 2UnknownIzmir Bakircay University602024-10-102024-09-26
Effect Of Abdominal Hypopressive Training On Stress Urinary Incontinence
pelvic floor exercises, nutritional instructions, abdominal hypopressive exercises, pelvic floor exercises, nutritional instructions - Female Stress Urinary Incontinence
Phase 2CompletedBadr University502024-08-202025-03-06
Autologous Muscle Stem Cell Therapy for Treatment of Congenital Urinary Incontinence in Epispadias Patients
Primary human muscle stem cells (Satori-01), Placebo - Urinary Incontinence, Epispadias, Male
Phase 1 / Phase 2Not yet recruitingSimone Spuler, MD212024-06-012023-08-03
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Elidah Device - Urinary Urge Incontinence, Stress Urinary Incontinence
Phase 2RecruitingNational Cancer Institute (NCI)412024-02-152026-11-10
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
OnabotulinumtoxinA - Urinary Incontinence, Overactive Bladder Syndrome
Phase 2 / Phase 3Active not recruitingNorthwestern University662023-07-132026-11-06
Reduced-dose Botox for Urgency Incontinence Among Elder Females
Botox 50 Unit Injection, Botox 100 Unit Injection - Overactive Bladder, Urinary Incontinence in Old Age
Phase 1 / Phase 2Active not recruitingDartmouth-Hitchcock Medical Center3762023-05-122026-02-03
Lidocaine Patches Prior to Percutaneous Nerve Evaluation
Lidocaine patch, Placebo - Overactive Bladder, Urge Incontinence
Phase 2CompletedUniversity of Louisville392023-05-012025-02-03
Feasibility Study of A VoRo UrologIc ScaffolD (ARID)
Voro Urologic Scaffold - Stress Urinary Incontinence, Radical Prostatectomy
Phase 2Active not recruitingLevee Medical, Inc.402023-04-032025-03-06
Stress Urinary Incontinence Study to Assess Safety and Efficacy of Muvon's Muscle Precursor Cell Therapy
autologous muscle precursor cells - Female Stress Urinary Incontinence
Phase 2CompletedUniversity of Zurich302022-10-172025-08-08
A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence
EG017 3mg, EG017 6mg - Stress Urinary Incontinence
Phase 2CompletedChangchun GeneScience Pharmaceutical Co., Ltd.512022-01-062023-01-06
Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Complications
UVT - Female Stress Incontinence, Stress Urinary Incontinence
Phase 2CompletedTBF Genie Tissulaire162021-11-082024-06-05
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
Sildenafil Citrate, Placebo - Spinal Cord Injuries, Urinary Incontinence
Phase 2Active not recruitingThe University of Texas Medical Branch, Galveston242021-07-072026-09-09
Platelet Rich Plasma in Women With Urinary Incontinence
Platelet Rich Plasma Injections, Normal Saline Injections - Urinary Incontinence, Stress Urinary Incontinence
Phase 2 / Phase 3UnknownNational and Kapodistrian University of Athens502021-07-012021-11-09
Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB)
Placebo, BAY1817080 - Overactive Bladder
Phase 2CompletedBayer992020-09-162022-12-22
A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence
TAS-303 18 mg/day, Placebo - Stress Urinary Incontinence
Phase 2CompletedTaiho Pharmaceutical Co., Ltd.2312020-09-042022-02-10

Showing 20 of 107. Sign in to see all of them.

Narrower conditions

Urinary Incontinence, Stress (46)  ·  Urinary Bladder, Overactive (25)  ·  Urinary Incontinence, Urge (19)  ·  Spinal Cord Injuries (5)  ·  Fecal Incontinence (4)  ·  Lower Urinary Tract Symptoms (4)  ·  Prostatic Neoplasms (4)  ·  Pelvic Organ Prolapse (3)  ·  Urologic Diseases (3)  ·  Encopresis (2)  ·  Erectile Dysfunction (2)  ·  Urological Manifestations (2)  ·  Anxiety Disorders (1)  ·  Bladder Exstrophy (1)

Broader conditions

Female Urogenital Diseases (107)  ·  Female Urogenital Diseases and Pregnancy Complications (107)  ·  Male Urogenital Diseases (107)  ·  Pathological Conditions, Signs and Symptoms (107)  ·  Urogenital Diseases (107)  ·  Signs and Symptoms (106)  ·  Urination Disorders (106)  ·  Urological Manifestations (105)  ·  Urologic Diseases (104)  ·  Lower Urinary Tract Symptoms (103)  ·  Urinary Bladder Diseases (26)  ·  Nervous System Diseases (8)  ·  Central Nervous System Diseases (6)  ·  Genital Diseases (6)

Interventions

Botulinum Toxins, Type A (7)  ·  ostarine (4)  ·  Duloxetine Hydrochloride (3)  ·  Solifenacin Succinate (3)  ·  Tolterodine Tartrate (3)  ·  mirabegron (3)  ·  Acupuncture Therapy (2)  ·  Exercise Therapy (2)  ·  Suburethral Slings (2)  ·  TAS-303 (2)  ·  Anesthesia, Local (1)  ·  Biopsy (1)  ·  Cannabidiol (1)  ·  Gentamicins (1)  ·  High-Intensity Focused Ultrasound Ablation (1)

Sponsors

Cook MyoSite (4)  ·  GTx (4)  ·  Eli Lilly and Company (3)  ·  Guang'anmen Hospital of China Academy of Chinese Medical Sciences (3)  ·  Kasr El Aini Hospital (3)  ·  Pfizer (3)  ·  Ain Shams University (2)  ·  Allergan (2)  ·  Astellas Pharma Europe B.V. (2)  ·  Glostrup University Hospital, Copenhagen (2)  ·  Hadassah Medical Organization (2)  ·  Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (2)  ·  Instituto de Investigación Hospital Universitario La Paz (2)  ·  Klinikum der Universität Köln (2)  ·  Taiho Pharmaceutical Co., Ltd. (2)

Countries

United States (40)  ·  Canada (12)  ·  Germany (11)  ·  United Kingdom (8)  ·  Denmark (7)  ·  Egypt (6)  ·  France (6)  ·  Czechia (5)  ·  Netherlands (5)  ·  Poland (5)  ·  Spain (5)  ·  Sweden (5)  ·  Belgium (4)  ·  China (4)  ·  Australia (3)

Top investigators

Kenneth Peters, MD (4)  ·  Ran Pang, MD (2)  ·  Sergio Alonso Gregorio, MD (2)  ·  Wolfram H Jager, PhD (2)  ·  Abd-Elmoneim Shawky Shams El-deen, MD (1)  ·  Abdel-Wahab El-Okby, MD (1)  ·  Abeer ElDeeb, Professor (1)  ·  Adriano Dias, Dr. (1)  ·  Ahmed Said Sayed Bayomy, MSc (1)  ·  Alexander Nechiporenko, Dr (1)  ·  Amy Krambeck, MD (1)  ·  Angelo E Gousse, MD (1)

Results publications

PMID 37160401, PMID 10895973, PMID 15014939, PMID 15791633, PMID 16673051, PMID 19183825, PMID 19375093, PMID 19625327, PMID 20093904, PMID 20384395, PMID 20639026, PMID 21358718, PMID 22036776, PMID 22341290, PMID 22342057, PMID 22464310, PMID 22512844, PMID 22704099, PMID 23218404, PMID 23424164, PMID 24079823, PMID 24258099, PMID 24612659, PMID 24987412, PMID 25800900, PMID 26377550, PMID 26465164, PMID 28655016, PMID 31008950, PMID 31919102, PMID 32378735, PMID 32769645, PMID 33894146, PMID 34699062, PMID 34978027, PMID 34988092, PMID 36409639, PMID 37144409, PMID 37493287, PMID 37888839, PMID 38979756, PMID 39704322, PMID 40013530, PMID 41546699, PMID 41649019

NIH funding

2009 (2), 2019 (1), P50HD044406 (1), R01AT002175 (1), R01DK136904 (1), R01NR012011 (1), U01HD041249 (1), U10HD041250 (1), U10HD041261 (1), U10HD041267 (1), U10HD054136 (1), U10HD054214 (1), U10HD054215 (1), U10HD054241 (1)